Rethinking Clinical Trials

AUGUST 16, 2023

Landry is a professor of medicine and epidemiology at Oxford Population Health and deputy director of the University of Oxford’s Big Data Institute. Landry is a professor of medicine and epidemiology at Oxford Population Health and deputy director of the University of Oxford’s Big Data Institute.

Clinical Trials 130

Clinical Trials Clinical Trials Big Data Trials 130

Pharmaceutical Technology

OCTOBER 27, 2022

Belfast startup AMPLY has raised £900,000 to develop a range of new products that hopes to tackle multi-drug resistent pathogens using its artificial intelligence (AI) drug discovery platform. The post AI medtech platform is aiming to tackle drug-resistant pathogens appeared first on Pharmaceutical Technology.

Drugs 147

Drugs Big Data Bacteria Development 147

Drug Discovery World

JULY 20, 2023

The EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. The use of AI is rapidly developing in society and as regulators we see more and more applications in the field of medicines. “The

Drugs 40

Drugs Regulation Medicine Big Data 40

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. What, then, is the solution?

Development 135

Development Research Drugs Clinical Trials 135

Drug Discovery World

DECEMBER 20, 2022

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. They also expect that decentralised, adaptive and digitalised clinical trials will provide the opportunity to collect data more widely and efficiently next year. .

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

pharmaphorum

NOVEMBER 24, 2022

Two years ago, the EMA proposed a set of recommendations to unlock the potential of big data for public health, headlined by the creation of a platform to access and analyse healthcare data from across the bloc. With the first data partners on board, the regulator can now move ahead with the start of its first studies.

Big Data 52

Big Data Biobanking Regulation Medicine 52

Roots Analysis

APRIL 4, 2023

In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.

Big Data 52

Big Data Life Science Development Clinical Trials 52

The Pharma Data

JULY 12, 2021

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. the success rates in drug discovery?are

Drugs 52

Drugs Gene Expression Big Data Gene 52

ACRP blog

JUNE 13, 2024

The article bolsters the issue’s “Let’s Get Personal: Scaling Clinical Research Down to You and Me” theme as it joins several other contributed pieces focused on patient centricity and personalized or precision medicine topics. Regulatory authorities, notably the U.S.

52

52

Drug Discovery World

SEPTEMBER 7, 2022

The concept of Artificial Intelligence (AI) never fails to stimulate and in drug discovery the possibilities it presents, the potential it holds, are always thought-provoking, says DDW Publishing Director Lu Rahman. . We are well aware of the time and cost involved in developing a new drug.

Drugs 52

Drugs Development Licensing Licensing 52

ACRP blog

APRIL 5, 2023

AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This will also allow companies to utilize advanced computational models to find better treatments more quickly while also reducing costs associated with drug development.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

pharmaphorum

MAY 23, 2022

The results generated in the study will be combined with data from Tohoku’s Medical Megabank Project (TMM), a wide-ranging national project that is tracking the health of the Japanese population, originally set up in response to the 2011 earthquake and tsunami.

Big Data 90

Big Data Genome Genomics Development 90

XTalks

MAY 9, 2024

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

DECEMBER 27, 2023

You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts. These are just some of the words that come to mind when talking about not just the drug discovery sector, but the lives of those working in and around it. He speaks about this drug discovery journey here. Developing. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Auransa, which harnesses available data to discover highly intractable diseases with poorly understood biology.

Marketing 69

Marketing Medicine Genome Genomics 69

pharmaphorum

OCTOBER 26, 2021

Only sustainable, robust supply chains and business models will allow innovation to flourish, secure access to medicines, and minimise the industry’s impact on the environment. It is obvious, said Daniell, that “predictable and sustainable access to quality medicines” has to sit at the heart of Europe’s health agenda.

Manufacturing 122

Manufacturing Medicine Big Data Development 122

pharmaphorum

FEBRUARY 1, 2022

His research focuses on the development of big data machine learning for tracking the health of complex systems. He has carried a drug candidate continuously from early preclinical development throughout to market authorisation with an innovative application strategy, including a novel and innovative real-world data approach.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Engineer 105

Drug Discovery World

AUGUST 22, 2023

Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. What are complex generics?

Production 52

Production Bioequivalency In-Vivo In-Vitro 52

pharmaphorum

MAY 25, 2021

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine. The study measured the impact of next generation inhaled lung drugs on COPD and he said it had a lower drop-out rate than other similar studies. About BREATHE.

Big Data 135

Big Data Clinical Research Research Trials 135

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

Drug Discovery World

MAY 4, 2023

Professor Sonika Bhatnagar explores how artificial intelligence is enabling drug discovery at rates never seen before. Here started the story of drug discovery. The magic bullet was the drug, while the specific mark it would reach in the syphilis causing bacteria to eliminate the disease was the drug target.

Medicine 52

Medicine Protein Drugs Bioassay 52

pharmaphorum

SEPTEMBER 18, 2020

The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin. However, it withdrew its neuropharmacological drug, Zelmid, which was an SSRI, due to concerns over side effects only a year after it was introduced in 1982. Zeneca Group plc.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Delveinsight

AUGUST 18, 2021

The Diabetes medications prescribed are broadly classified into two categories, oral drugs, and injectable medicines. Distinctive improvement has been made in the development of targeted medicine. Dipeptidyl peptidase-4 (DPP-4) inhibitors (also known as gliptins) are a new class of oral drugs. Insulin Innovations.

Insulin 94

Insulin Marketing Development Big Data 94

Drug Discovery World

SEPTEMBER 6, 2022

There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. billion in 2020, according to the Alliance for Regenerative Medicine’s (ARM’s) Regenerative Medicine: Disrupting the Status Quo report. billion, compared to $19.9 million price point per dose. Cancer is king .

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

Delveinsight

FEBRUARY 17, 2021

Almost all the aspects of the healthcare sector, such as service delivery, communications, operation, medical equipment, and drug development, have grown remarkably and improved the overall health outcome. Improvement in the diagnostics, management of chronic conditions, drug and device development, are some of the key applications of AI.

Doctors 52

Doctors Doctor Big Data Development 52

Drug Discovery World

OCTOBER 12, 2022

Having these new data leads to greater understanding and enables precision medicine. . Mark Matson is a research professional with more than 25 years in drug development, sales leadership, licensing, and program management. Why are digital biomarkers important in clinical trials? . About the author .

Clinical Trials 52

Clinical Trials Clinical Trials Trials Sales 52

Drug Discovery World

SEPTEMBER 5, 2022

Throughout the continuum of drug development, from target discovery to patient selection, machine learning approaches are being adopted to reliably mine vast amounts of data and make predictions with higher accuracy Anita Ramanathan discusses how machine learning is currently used across different stages of cancer research. .

Development 52

Development Drugs Protein Genome 52

Drug Discovery World

AUGUST 9, 2023

DB: We have three priorities as an oncology business: supporting earlier diagnosis and treatment; enabling the implementation of precision medicines; and working in partnership with the NHS to optimise patient pathways. Another area of research which is really exciting for the whole industry is genomics and genetically targeted medicines.

Drugs 52

Drugs Antibody Big Data Medicine 52

Pharmaceutical Technology

NOVEMBER 1, 2022

Countries like Estonia and Finland have taken on a completely digitised approach to their health services , integrating EHR data to efficiently prescribe medications and improve treatment strategies. Darwin is part of a package of projects and initiatives to transform to data-driven medicines regulation.”.

Big Data 278

Big Data Regulation Medicine Research 278

The Pharma Data

JANUARY 12, 2021

a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process. 13, 2021 13:00 UTC.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

DECEMBER 8, 2022

These groundbreaking discoveries ushered in a new age of precision and personalized medicine, leading to innovations in novel targeted proteins, cell and gene therapies, and medical devices, which are often accompanied by bespoke diagnostic and testing criteria. The evidence‑generation process has become far more challenging.

Big Data 96

Big Data Gene Therapy Medicine Marketing 96

Cloudbyz

SEPTEMBER 25, 2020

HEPAprint – Adverse Drug Reaction (ADR). Clinical trials play a pivotal role in drug development. Understanding the possible scenarios relating to drug safety with the help of technology proves beneficial for all stakeholders. British startup HEPAprint develops predictive software to prevent adverse drug reactions.

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

Roots Analysis

DECEMBER 29, 2023

Clinical Trials: Clinical trials are research investigations in which people are subjected to a medicinal, surgical, or behavioral intervention. These trials are the primary means by which researchers evaluate whether a new type of therapy or prevention, such as a new medicine, diet, or medical gadget, will be effective.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharma Marketing Network

JUNE 11, 2020

Big Data was a critical topic. But that could be changing soon. We sat down, we said, well, what are the critical topics we want to talk about? And some of those topics at the time, you know, the ACA was in its infancy, that was a critical topic to talk about.

Marketing 52

Marketing Branding Regulation Production 52

Drug Discovery World

NOVEMBER 18, 2022

World Antimicrobial Awareness Week highlights the fact that antimicrobials have formed the bedrock of modern medicine, making surgeries, cancer care and treatments for life-threatening infections possible and improving human health in the process. . Dynobactin and Darobactin, potential drugs could be further improved and optimised.? .

Bacteria 52

Bacteria Drugs Development Research 52